Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.6 SEK | 0.00% |
|
+0.39% | +61.76% |
06-18 | Calliditas Therapeutics Gets US Patent for Cancer Treatment Candidate | MT |
06-18 | Calliditas Therapeutics Secures US Patent for Cancer Treatment Inhibitor | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.76% | 1.04B | |
+7.39% | 72.4B | |
+15.93% | 8.98B | |
+17.59% | 4.28B | |
-22.81% | 4.28B | |
+25.93% | 4.01B | |
+4.64% | 2.16B | |
+9.09% | 1.95B | |
-36.86% | 1.9B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Transcript : Calliditas Therapeutics AB - Special Call